
TSLA
- Market cap
- $786B
- Sector
- Consumer discretionary

Stored run, base case: $132.51 · difference under 0.1%.
Value per share against today's price
The multiple the final year is sold at
Higher means a lower value
A year, for 10 years held
Sensitivity: discount rate × exit multiple
Value per share at each pairing. The outlined cell is the pairing the rail is set to.
| Exit multiple → | |||||
|---|---|---|---|---|---|
| Discount rate | 51.5× | 52.5× | 53.5× | 54.5× | 55.5× |
| 11.73% | $139.09 | $141.61 | $144.13 | $146.65 | $149.18 |
| 12.23% | $133.35 | $135.77 | $138.18 | $140.59 | $143.00 |
| 12.73% | $127.89 | $130.20 | $132.51 | $134.82 | $137.12 |
| 13.23% | $122.69 | $124.90 | $127.11 | $129.32 | $131.52 |
| 13.73% | $117.74 | $119.85 | $121.96 | $124.08 | $126.19 |
Both axes step around the rail's own settings, so the grid re-centres whenever you move one.
Exit multiple vs historical EV / EBITDA
Exit multiple 53.5× vs the company's own multiple by fiscal year, oldest first.
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Company EV / EBITDA | 78.6× | 77.5× | 69.3× | 66.1× | 62.4× |
| Exit 53.5× vs it | −32% | −31% | −23% | −19% | −14% |
Implied perpetual growth at 53.5×: 12.55%
The growth for ever, after year 10, at which the final year's free cash flow to the firm, discounted at 12.73%, is worth what the sale fetches.
A rate near 2–3% is usually read as consistent with a mature business. Well above it, the multiple carries growth the forecast itself stops short of.
Valuation build-up
Dollars per share: the enterprise figures divided by the share count.
| Per share | Share | Amount |
|---|---|---|
| EBITDA per share, current | $3.82 | |
| EBITDA per share, year 10 | $7.64 | |
| PV of exit value at 53.5× | 93% | $123.47 |
| PV of interim free cash flow to the firm | 2% | $2.50 |
| Less: net debt per share | −$6.54 | |
| Value per share | $132.51 |
Methodology
Ten years of EBITDA, sold at an exit multiple, with free cash flow to the firm credited along the way and the debt subtracted at the end.
| Construction | Recorded |
|---|---|
| EBITDA in 2036 | $24.5B |
| Multiple applied | 53.5× |
| Supported multiple range | 14.2× to 79.7×, median 53.5× |
| Holding period | 10 years |
| Phase-2 start | year 6 |
| Discount rate (WACC) | 12.73% |
| Less: net debt per share | −$6.54 |
| Value per share | $138.49 |
Scenarios and weights
Dollars per share. Each case moves the growth path and the multiple together, because a slower business sells for less.
| Case | Weight | Growth | Then | Sold at | Value per share | vs price |
|---|---|---|---|---|---|---|
| Negative | 20% | 4.0% | 2.4% | 45.5× | −67.3% | |
| Base | 60% | 9.0% | 5.4% | 53.5× | −45.9% | |
| Optimistic | 20% | 14.1% | 8.4% | 61.5× | −12.2% |
Weighted answer $138.49, which is the figure on this card.
Multiple rationale
Its own five-year average is 79.7× and the sector median is 14.2×; the choice sits at 53.5×, three parts the first and two parts the second. The size-ranked comparables run from 9.2× to 27.1× and set nothing here. Applied to EBITDA in 2036, discounted once at 12.7%. Every case grows faster than the 5.9% this business can fund out of its own returns, which is a finding about the base case and not only about the optimistic one.
Its own five-year average and the sector median are the two benchmarks the relative-valuation tab publishes for the same ratio.
Size-matched comparables
Context only. None of these enters the multiple above.
| Company | Multiple | vs applied |
|---|---|---|
| AVGO Broadcom | −49% | |
| JPM JPMorgan | −83% | |
| UNH UnitedHealth | −74% |